CCOJY yields 1.20% · JNJ yields 2.13%● Live data
📍 CCOJY pulled ahead of the other in Year 1
Combined, CCOJY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCOJY + JNJ for your $10,000?
Coca-Cola Bottlers Japan Holdings Inc., together with its subsidiaries, engages in the purchase, bottling, packaging, distribution, marketing, and sale of carbonated, coffee, tea-based, mineral water, alcohol, and other soft drinks in Japan. The company offers its products under the Coca-Cola, Fanta, Sprite, Real Gold, Georgia, Aquarius, Qoo, Sokenbicha, Huang, and Kochakaden brand names. It also develops, manufactures, and sells various healthcare products; manufacture and sells food products; operates vending machines; and manages beverage sales equipment. In addition, the company provides shared services to support the sales of, nonessential, alcoholic, and dairy beverages, as well as food products; real estate rental and leasing, selling, purchasing, brokerage, and management services; and insurance agency services. It sells its products through convenience stores and vending machines. The company was formerly known as Coca-Cola Bottlers Japan Inc. and changed its name to Coca-Cola Bottlers Japan Holdings Inc. in January 2018. Coca-Cola Bottlers Japan Holdings Inc. was incorporated in 1960 and is headquartered in Tokyo, Japan.
Full CCOJY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.